Relation between blood pressure time in range and composite cardiovascular disease in patients with primary aldosteronism: a retrospective study
Author:
Yan Fangfang1ORCID, Yu Huangdao1, Lan Liping2, Xu Ziqing1, Zeng Jingyang1, Huang Bingkun1, Liu Changqin1, Li Xuejun1, Lin Mingzhu1
Affiliation:
1. The First Affiliated Hospital of Xiamen University 2. Luoyuan county hospital
Abstract
Abstract
Purpose: To investigate the association between blood pressure (BP) time in range (TIR) and composite cardiovascular disease (CVD) in patients with primary aldosteronism (PA).
Methods: Between January 2019 and December 2021, 47 patients with PA were recruited from the First Affiliated Hospital of Xiamen University. Twenty-four-hour ambulatory BP monitoring (ABPM) and composite CVD events were assessed in all patients.
Results: The mean age of the patients was 48.8 ± 11.4 years. Compared to PA without composite CVD events, the nighttime systolic BP TIR [31.2% (6.2%, 81.2%) vs. 11.5% (0.0%, 29.7%), p = 0.02] and DDDs of antihypertensive medication [2.0 (1.0, 2.8) vs. 1.0 (1.0, 2.0), p = 0.03] were lower in PA patients with composite CVD events, while higher glucose (5.0 ± 1.0 mmol/L vs. 5.9 ± 1.5 mmol/L) and prevalence of a history of alcohol intake was higher in PA patients with composite CVD events. There were no differences in age, sex, BMI, smoking, duration of hypertension, lipid levels, aldosteronism, clinic BP, 24-hour mean BP, daytime or nighttime BP, percentage of nocturnal SBP or DBP decline, 24-hour BP TIR, daytime BP TIR, or nighttime DBP TIR between the two groups. After adjusting for confounding factors, nighttime systolic BP TIR was significantly associated with composite CVD events (adjusted OR = 0.92 [95% CI 0.86, 0.99]) in multiple logistic regression analysis.
Conclusion: Patients with PA and composite CVD events had lower nighttime SBP TIR, suggesting that nighttime BP TIR may be a significant predictor of the prognosis of composite CVD events.
Publisher
Research Square Platform LLC
Reference26 articles.
1. P.K. Whelton, R.M. Carey, W.S. Aronow, D.E. Jr Casey, K.J. Collins, C. Dennison Himmelfarb, S.M. DePalma, S. Gidding, K.A. Jamerson, D.W. Jones, E.J. MacLaughlin, P. Muntner, B. Ovbiagele, S.C. Jr Smith, C.C. Spencer, R.S. Stafford, S.J. Taler, R.J. Thomas, K.A. Williams, J.D. Sr, Williamson, J.T. Jr. Wright, ACC/AHA/AAPA/ABC/ACPM /AGS/APhA/ASH, /ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006. Epub 2017 Nov 13. Erratum in: J Am Coll Cardiol. 2018;71(19):2275–2279. PMID: 29146535 2. Ambulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension;Huang QF;Hypertension,2021 3. J.A. Staessen, L. Thijs, R. Fagard, E.T. O'Brien, D. Clement, de P.W. Leeuw, G. Mancia, C. Nachev, P. Palatini, G. Parati, J. Tuomilehto, J. Webster, Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282(6):539 – 46. 10.1001/jama.282.6.539. PMID: 10450715 4. International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators. Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes;Yang WY;JAMA,2019 5. M. Liu, Y. Li, F.F. Wei, L. Zhang, J.L. Han, J.G. Wang, Is blood pressure load associated, independently of blood pressure level, with target organ damage? J Hypertens. 2013;31(9):1812-8. 10.1097/HJH.0b013e3283624f9b. PMID: 23743810
|
|